Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy

Abstract Background The fecal immunochemical test (FIT) is the second most commonly used colorectal cancer (CRC) screening modality in the United States; yet, follow-up of abnormal FIT results with diagnostic colonoscopy is underutilized. Our objective was to determine patient-reported barriers to d...

Full description

Bibliographic Details
Main Authors: Vivy T. Cusumano, Edgar Corona, Diana Partida, Liu Yang, Christine Yu, Folasade P. May
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Gastroenterology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12876-020-01262-7